scholarly journals OP12.01: Examination of the fetal heart by four-dimensional ultrasound with spatiotemporal image correlation: potential for second-trimester screening of congenital heart disease

2007 ◽  
Vol 30 (4) ◽  
pp. 493-493
Author(s):  
G. Rizzo ◽  
A. Capponi ◽  
O. Cavicchioni ◽  
M. Vendola ◽  
D. Arduini
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Fetal Heart ◽  
Image Correlation ◽  
Second Trimester ◽  
Second Trimester Screening ◽  
Correlation Potential ◽  
Trimester Screening ◽  
Spatiotemporal Image Correlation

Prenatal detection of congenital heart disease in a low risk population undergoing first and second trimester screening

2015 ◽  
Vol 35 (4) ◽  
pp. 325-330 ◽  
Author(s):  
Ditte E. S. Jørgensen ◽  
Niels Vejlstrup ◽  
Connie Jørgensen ◽  
Lisa Leth Maroun ◽  
Jesper Steensberg ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Low Risk ◽  
Second Trimester ◽  
Risk Population ◽  
Prenatal Detection ◽  
Second Trimester Screening ◽  
Trimester Screening

scholarly journals HDlive of the Fetal Heart

2014 ◽  
Vol 8 (3) ◽  
pp. 266-272 ◽  
Author(s):  
Hirokazu Tanaka
Keyword(s):  
Congenital Heart Disease ◽  
Congenital Heart ◽  
Obstet Gynecol ◽  
Fetal Heart ◽  
Fetal Echocardiography ◽  
Image Correlation ◽  
Cardiac Anatomy ◽  
Novel Technique ◽  
Spatiotemporal Image Correlation ◽  
New Skin

ABSTRACT We present the latest HDlive echocardiographic studies on the fetal heart using spatiotemporal image correlation (STIC). Fetal HDlive echocardiography with the use of new skin-like colors provides sonographers and physicians with a natural and anatomically realistic appearance of the fetal heart. Moreover, HDlive images provide entirely new visual experiences for obstetricians and pediatric cardiologists owing to the anatomically realistic depiction of the normal fetal heart and fetal congenital anomalies in utero. This novel technique may assist in the evaluation of the fetal cardiac anatomy, and offer potential advantages relative to conventional two-, three-, and four-dimensional fetal echocardiography. HDlive may be an important modality in future fetal cardiac research and in the evaluation of fetal congenital heart disease. How to cite this article Hata T, Kanenishi K, Hanaoka U, Tanaka H. HDlive of the Fetal Heart. Donald School J Ultrasound Obstet Gynecol 2014;8(3):266-272.

scholarly journals HDlive Flow silhouette mode and spatiotemporal image correlation for diagnosing congenital heart disease

2017 ◽  
Vol 50 (3) ◽  
pp. 411-415 ◽  
Author(s):  
M. Ito ◽  
M. A. M. AboEllail ◽  
K. Yamamoto ◽  
K. Kanenishi ◽  
H. Tanaka ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Image Correlation ◽  
Spatiotemporal Image Correlation

Abstract 16738: Association Between First and Second Trimester Maternal Screening Biochemistry, Ultrasound, and Fetal Brain Growth in Presence of Fetal or Maternal Congenital Heart Disease

Circulation ◽  
2020 ◽  
Vol 142 (Suppl_3) ◽  
Author(s):  
Aman Sharma ◽  
Emma Lewis ◽  
Gabrielle Gray ◽  
Jennifer R Maldonado ◽  
Diana L Knoedel ◽  
...  
Keyword(s):  
Congenital Heart Disease ◽  
Heart Disease ◽  
Congenital Heart ◽  
Fetal Brain ◽  
Nuchal Translucency ◽  
Second Trimester ◽  
Fetal Head ◽  
Placental Dysfunction ◽  
Z Scores ◽  
Hormonal Levels

Introduction: Newer research has highlighted significant neurological impairments in children and adults with congenital heart disease (CHD). The more severe the heart defect, the higher the neurologic impairment. Pregnancies complicated by fetal or maternal CHD carry a higher risk of placental abnormalities. We studied the association between pregnancy hormonal levels and fetal head and body growth. Hypothesis: Placental dysfunction in pregnancies with fetal or maternal CHD alters pregnancy hormonal levels affecting fetal brain and somatic growth. Methods: We performed a retrospective case-control study on pregnant women (year 2010-2019) at the University of Iowa. Only women with first and/or second trimester prenatal screening (ultrasound and blood test) were included. Pregnancies with fetal chromosomal abnormalities, multiple gestation, maternal diabetes, smoking, or hypertension were excluded. Pregnancies were either healthy controls (n=36), women with CHD (MCHD; n=26), or fetus with CHD (FCHD; n=23). Pregnancy hormonal levels, ultrasound findings, and fetal/neonatal growth percentiles and/or z-scores data were analyzed. Results: Women with CHD were younger (p=0.004) with increased fetal nuchal translucency (p=0.003) compared to controls. Women in MCHD (p=0.02) and FCHD (p=0.02) group delivered earlier than controls. FCHD had significantly lower pregnancy associated plasma protein-A (PAPP-A) levels than controls (p=0.04). The groups had no difference in the second trimester fetal head circumference (HC) and femur length. FCHD group had significantly smaller HC percentile (p=0.03) and z-scores (p=0.03) at birth than controls. Both FCHD and MCHD had smaller birth weight and length compared to controls. However, only FCHD group demonstrated significantly lower HC to birth weight ratio (p=0.01). The controls had a positive correlation between human chorionic gonadotropin level and head circumference z-score at birth (r=0.34;p=0.053). Conclusions: Pregnant women with CHD have increased fetal nuchal translucency and deliver at earlier gestational age. Women with fetal CHD have smaller neonatal head and body size at birth with associated low PAPP-A level early in their pregnancy probably related to placental dysfunction.

Sign in / Sign up

Export Citation Format

Share Document